Optimal treatment strategies for coronary artery disease in patients with advanced kidney disease: a meta-analysis.
Jingwen YongJinfan TianXin ZhaoXueyao YangHaoran XingYi HeXiantao SongPublished in: Therapeutic advances in chronic disease (2021)
In patients with advanced kidney disease and CAD, PCI reduced the risk of short-, medium- and long- term (more than 3 years) all-cause death compared with MT. Compared with PCI, CABG was associated with a high risk of short-term death and a low risk of long-term death and adverse events.
Keyphrases
- coronary artery disease
- coronary artery bypass grafting
- percutaneous coronary intervention
- cardiovascular events
- acute myocardial infarction
- acute coronary syndrome
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- atrial fibrillation
- type diabetes
- heart failure
- left ventricular
- cardiovascular disease
- coronary artery bypass
- aortic stenosis